Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIP-HF: Colchicine in patients with clonal hematopoiesis and heart failure with reduced ejection fraction
2021-001508-13Phase 2Active
- Sponsor
- Goethe University Frankfurt
- Start
- May 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure with reduced ejection fraction (HFrEF) and ischaemic cardiomyopathy (ICM) comparing Colchicine with Placebo (2 arms). Started May 2021; status: active.
02
Drugs
colchicine
03
Conditions
heart failure with reduced ejection fraction (HFrEF)ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on 2021-001508-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001508-13.